30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Biologics4Life Secures License to Bone Tissue Regeneration Technology -

Biologics4Life completed an exclusive licensing agreement to secure rights to initial technologies for advanced bone tissue regeneration. This agreement strengthens the company’s intellectual property portfolio and is a step toward the development of its scaffold materials. The milestone lays the groundwork for the company's 2020 and 2021 objectives: completion of manufacturing engineering and market launch. Biologics4Life is an early stage orthobiologics company developing a range of patented biomaterials for bone regeneration. The company seeks to create a pipeline of advanced biomaterials to provide modular options for the treatment of bone voids and lesions.